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Aim: Mycoplasma pneumoniae is involved in the etiology of many respiratory tract infections. This prospective study describes the
epidemiology and clinical properties of M. pneumoniae infections in hospitals of the Tabriz University of Medical Sciences.
Materials and methods: From May 2009 to November 2010, 200 patients with respiratory tract infections were enrolled into this study.
Due to antibiotic use 51 patients were excluded. M. pneumoniae from respiratory infections was detected by culture, enzyme-linked
immunosorbent assay (ELISA), and polymerase chain reaction (PCR) assays.
Results: M. pneumoniae infection was detected in 9 (6.15%), 8 (5.3%), and 3 (2.01%) of patients by PCR, ELISA, and culture methods,
respectively. M. pneumoniae infection was mostly prevalent in patients 21–80 years old. Most infections (92%) were communityacquired and coughs, fever, dyspnea, and malaise were among the most common symptoms.
Conclusion: Pneumonia due to the M. pneumoniae infection is infrequent in Tabriz and the clinical symptoms of the patients were
determined to be mild. The PCR method also proved to be more sensitive and reliable than ELISA and culture assays in the detection
of M. pneumoniae.
Key words: Mycoplasma pneumoniae, pneumonia, epidemiology

1. Introduction
Mycoplasma pneumoniae infections happen both
endemically and epidemically worldwide (1). M.
pneumoniae is a member of a group of organisms, including
Chlamydia pneumoniae and Legionella pneumophila, that
cause atypical pneumonia (2). This bacterium is currently
responsible for 10%–20% of all radiographically proven
pneumonias and up to 25% of all pediatric primary
atypical pneumonias (3). Although it is extremely
contagious, most infections from M. pneumoniae are
relatively mild and consist of low-grade fever, malaise,
headache, dyspnea, fatigue, nonproductive cough,
pharyngitis, tracheobronchitis, and bronchiolitis (4). Only
3%–10% of infected cases result in bronchopneumonia
and death from Mycoplasma infection is uncommon,
different from cases of Streptococcus pneumoniae infection
(5,6). Myalgia and gastroenteritis are infrequent, and
secondary complications include otitis media, erythema
multiform, hemolytic anemia, myocarditis, pericarditis,
and neurological abnormality (4). Pneumonia due to M.
pneumoniae occurs worldwide all through the year but it is
more common during summer and fall, and illness is most
* Correspondence: sharifi.ghazi@gmail.com

prevalent in people 5–20 years old (7). The main problem
with pneumonia due to M. pneumoniae is early diagnosis.
Therefore, recently there has been a tendency for early
detection of M. pneumoniae using very sensitive and fast
techniques, like the polymerase chain reaction (PCR)
assay (8). However, there has not been adequate research
about M. pneumoniae infections in East Azerbaijan, Iran.
The purpose of this study was thus to investigate the
epidemiology, laboratory detection, and clinical features
of infections caused by M. pneumoniae in this region.
2. Materials and methods
This randomized consecutive prospective study describes
the epidemiology and clinical properties of M. pneumoniae
infections in Tabriz hospitals. Clinical samples were
collected from 200 patients who were diagnosed with
upper respiratory tract infections (178 patients) and lower
respiratory tract infections (22 patients) based on clinical
symptoms, signs, and radiography. Patients complaining
of cough, fatigue, respiratory distress, fever, chilliness, sore
throat, sputum, malaise, chest pain, rales, and wheezes
were considered for the study. Written informed consent
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was obtained from the patients before they were enrolled
in the research, and the study protocol was approved
by the ethics committee of Tabriz University of Medical
Sciences. Due to their use of antibiotics, 51 patients were
excluded. If M. pneumoniae isolates were recovered from
nonhospitalized patients or within 48 h of entrance to the
hospital, they were considered as community-acquired
pneumonia. Pneumonia was identified based on clinical
signs and symptoms as well as radiodiagnostic data of
pneumonia in the case of some patients.
For detection of M. pneumoniae, respiratory tract
specimens were processed by 3 methods: culture, serology,
and PCR (3,7,8). Specimens for PCR and culture methods
were acquired from throat swabs (117 samples), sputum
(15 samples), endotracheal aspiration (3 samples),
bronchial washing (8 samples), and bronchoalveolar lavage
(6 samples). Blood samples were taken from patients for
serologic analyses. Laboratory diagnostic criteria were
according to results of PCR, serology, and culture assays.
In summary, broth and agar media were composed
of pleuropneumonia-like organism broth (PPLO, Difco),
horse serum, freshly prepared yeast extract supplemented
with thallium acetate (Sigma), glucose, and phenol red.
Specimens were inoculated in broth media and incubated
aerobically at 37 °C. Broth media were subcultured on
agar medium when the color changed to yellow. The
colonies were observed at 100× magnification in agar
medium. All the colonies obtained on the culture were
identified by Dine’s stain and by biological, biochemical,
and PCR assays. A commercially available enzyme-linked
immunosorbent assay (ELISA) kit (EUROIMMUN
Inc.) was used for quantitative and semiquantitative
determination of antibody titers (IgG and IgM) according
to the kit instructions. DNA was extracted from clinical
samples by boiling, and classical PCR was performed
using M. pneumoniae attachment protein (P1 primer) (7).
To increase the reliability of PCR results, positive PCR
product was sent for sequencing. Data were analyzed using
the chi-square and Fisher exact tests by SPSS 16.
3. Results
Of the 149 patients studied over the 10-month study
period, a total of 9 (6.15%) respiratory specimens were
PCR-positive for M. pneumoniae, while IgM ELISA
and culture methods revealed 8 (5.3%) and 3 (2.01%)
positive cases, respectively. It was interesting that all of the
culture- and IgM ELISA-positive patients were also PCRpositive. Elevated IgG anti-M. pneumoniae was detected
in 79 (53%) of the patients. The mean age of patients was
25 ± 2 years and the age range of patients was from 1 to
81 years old. The highest prevalence rate of M. pneumoniae
respiratory infection was diagnosed in patients 21–80
years old. All 9 patients with M. pneumoniae infection had
a cough; thus, coughs were the most common symptom,
and only 3 patients had sputum production with mild
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severity. Epidemiological and clinical manifestations of
the patients in this study are shown in the Table. Of all
the isolates, 88.9% were community-acquired and 11.1%
were nosocomial. Mean hospitalization duration was 17
± 9 days. Eighty-six of the suspected cases (58%) were
associated with pneumonia and 63 cases (42%) were
observed to involve upper respiratory tract infections.
4. Discussion
A variety of techniques are used to assess M. pneumoniae,
each with different advantages and disadvantages. In this
study, PCR, ELISA, and culture methods were employed
for the detection of M. pneumoniae infection in 149
suspected patients. The culture method for the isolation
of M. pneumoniae requires 2–4 weeks, which limits its
clinical usefulness. Moreover, culturing of M. pneumoniae
is expensive and time-consuming (2,3,9,10). Serological
methods are more extensively used than culture, because
they are easier to carry out and more affordable (7,11,12).
However, they are generally nonspecific, retrospective, and
need 2 samples for titration (2). It should be noted that in
our study, the most reliable result was obtained by the PCR
method, which proved to be highly sensitive, specific, and
faster than other methods. The specificity of the culture
method was 100%, while its sensitivity barely reached
33%, relative to the results of the PCR method as a gold
standard. All of the culture and IgM ELISA test positive
patients were PCR-positive, too. The PCR method is more
sensitive and is the gold standard currently being used for
diagnosis of this organism in some laboratories (13).
In a similar study carried out by Al-Rashed in Saudi
Arabia, M. pneumoniae was found in 6% of 112 adults (14).
In another study of community-associated pneumonia in
adult patients from Finland, the bacterium accounted for
30% of all episodes (15). In Turkey, M. pneumoniae was
diagnosed in 13% of patients by the real time-PCR method
(16). Naghipour et al. from Iran studied 261 children
with acute respiratory infections during 2003 to 2004
and detected M. pneumoniae in 2 cases (1%) by the PCR
method (17).
Other studies reported high levels of IgG antibody titer
in healthy people, perhaps because of previous infection
with M. pneumoniae, while IgM titer was elevated in
active infections (12,13). In our study 53% of the patients
had previous infection and 5.3% of them had active M.
pneumoniae respiratory infection. Our study demonstrated
that M. pneumoniae is one of the relatively uncommon
respiratory infections in East Azerbaijan, Iran. However,
the results of this study showed that the number of M.
pneumoniae infections has been underestimated, because
in the majority of community-acquired pneumonia cases,
individuals are treated as outpatients.
Climate, seasonality, and geography are not thought
to be of paramount significance; however, infection takes
place most commonly during fall and winter (2). Likewise,
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Table. Epidemiological and clinical characteristics of 9 patients with M. pneumoniae infections
Characteristics
Sex
Male
Female
Symptoms/signs
Cough
Fever
Malaise
Dyspnea
Fatigue
Skin manifestations
Chills
Myalgia
Diarrhea
Chest pain
Sputum production
Underlying disease
Asthma
Diabetes
Liver diseases
No underlying disease

Total patients,
n (%)*

Patients with M. pneumoniae
infections, n (%)**

77 (52)
72 (48)

4 (44.4)
5 (55.5)

134 (90)
57 (38)
52 (35)
70 (47.9)
68 (45.6)
18 (12)
33 (22.1)
36 (24)
16 (10.7)
34 (23)
55 (37)

9 (100)
5 (55.5)
5 (55.5)
5 (55.5)
4 (44.4)
2 (22.2)
2 (22.2)
2 (22.2)
2 (22.2)
1 (11.1)
3 (33.3)

4 (2.7)
4 (2.7)
1 (0.7)
125 (83.9)

4 (44.4)
2 (22.2)
1 (11.1)
2 (22.2)

*: 149 patients; **: 9 patients with M. pneumoniae infections detected by PCR.

in our study, M. pneumoniae infection was more prevalent
in the colder months, and this finding is consistent with
other studies (2,5,14). Our result revealed that most of the
infections were community-acquired (88.9%) and only
11.1% of patients had nosocomial infection; this result is in
agreement with other studies (2,5,9,14). It is interesting to
note that M. pneumoniae mainly affects people between 21
and 80 years old in this region. This finding is inconsistent
with reports from temperate countries, where the infection
is most frequent in school-aged children (7,15). The
identification of pneumonia was based on fever, dyspnea,
tachypnea, cough, and bronchopneumonic infiltration
distinguished via X-ray (18). The course of the disease was
varied, and cough persisted for several weeks. Overall, the
clinical features of infections with M. pneumoniae in our
cases were mild. However, some researchers have reported
that M. pneumoniae infections had a poor prognosis, with
a few fatal cases (5,7). We found that febrile patients had a
mild to moderate fever of 38 °C or less, while a high-grade
fever of more than 39 °C was rare. Cough was the most
common sign in patients and fever, malaise, dyspnea, and
fatigue were found in most patients in this study. Huong et
al. reported a fever of less than 38 °C and pharyngitis in all
patients, and a dry cough and dyspnea were found in most
cases (19). In our study, leukocytosis was also common
(67%) and the mean white blood cell count was 10,533
± 5000 cell/mm3. Clyde showed that M. pneumoniae
infection has a positive correlation with leukocytosis

(5). Interestingly, 44.4% of the patients suffered from
asthma along with M. pneumoniae respiratory infection.
Waites and Talkington and Nisar et al. reported that M.
pneumoniae infection may be related to asthma (10,20).
Smoking is globally related with pulmonary diseases (21),
but the results of this study did not show any significant
rise in M. pneumoniae infection among cigarette smokers
(P = 0.3).
In the Azerbaijan state of Iran, there is no national
epidemiological surveillance system for M. pneumoniae
infections; hence, the incidence of this infection was
unclear. To the best of our knowledge, this is the first report
of M. pneumoniae isolation from the northwest of Iran. We
found that none of the signs or symptoms were sufficient
to differentiate precisely M. pneumoniae infection, and M.
pneumoniae detection must be done by specific laboratory
tests. This research has shown that PCR is a highly sensitive
test, but the results from the current study suggest that
using a combination of tests may provide better diagnostic
information.
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